← Back to news
Y

Yahoo Finance

Billionaire Dan Loeb of Third Point Is Piling Into Nvidia for a 4th Consecutive Quarter, but Dumped His Fund's Entire Stake in This "Magnificent Seven" Stock

Y

Is Trane Technologies Stock Outperforming the S&P 500?

Y

Prism secures 10 Sonder properties for US debut of Belvilla

Y

Danske Commodities inks ten-year UK battery optimisation deal

Y

Safra CEO says Saxo deal shows need for tech scale in AI era

Y

Sandisk Stock Is Up 1,290% in the Past Year, but This AI Stock Could Soar When Memory Prices Stabilize

Y

Toyota Raises Offer for Unit, Ending Standoff With Elliott

Y

Former Optum chief departs UnitedHealth

Y

Stop calling it inevitable: The AI job crisis is being built, not born

Y

BrakeTime secures Little Caesars franchise agreement

Y

Oil Prices in Focus Following Iran Strikes, Goldman Sachs Says

Y

Worthington Steel Board Director Sells 2500 Shares Amid Major Acquisition

Y

Brent Crude Oil Analysis: $95 Target Reinforced, Double Bottom Intact

Y

Defense Stocks Jump, Airlines Slide as Iran Attack Jolts Markets

Y

Broadcom, Target Earnings and Jobs Report: What to Watch This Week

Y

Analysts Predict The Iran Conflict Could Drive Oil to $100 a Barrel. Here's Why it Could be a Short Stay.

Y

How Is CVS Health’s Stock Performance Compared to Other Healthcare Stocks?

Y

FTSE 100 Live: Iran war affects airlines and banks, natural gas prices soar

Y

Women in power: Scatec CDIO Kine Årdal conquers oil and gas, renewables and digitalisation

Y

Shell and BP shares lifted as oil and gas price spike on Iran war

Y

TransDigm Group Stock: Is TDG Underperforming the Industrial Sector?

Y

Yum China Holdings CEO Sells Over 100k Shares for $5M

Y

Vertex Gets Rating Upgrade, Earnings Rose Every Quarter This Past Year

Y

Is AbbVie Inc. (ABBV) One of the Best Cancer Stocks to Invest In Now?

Y

Revolution Medicines, Inc. (RVMD) Net Loss Widens amid Progress on Clinical Trial Programs

Y

Arvinas, Inc. (ARVN) Makes Significant Progress on Oncology and Neurology Trials

Y

Guardant Health, Inc. (GH) Strengthens Health Technology Portfolio with MetaSight Diagnostics Acquisition

Y

Cogent Biosciences Inc. (COGT) Set for Bezuclastinib Launch, Awaiting FDA Approval

Y

Immunome, Inc. (IMNM) Sets Sights on $1B Opportunity amid Pipeline Development

Y

Syndax Pharmaceuticals Inc. (SNDX) on a Strong Footing amid Robust Demand for Key Flagship Drugs

Y

Schrödinger, Inc. (SDGR) Transition to Licensing Model Triggers Robust Revenue Growth

Y

Nuvation Bio Inc. (NUVB) Amends Protocol on Safusidenib Trials in Astrocytoma

Y

Summit Therapeutics Inc. (SMMT) Focused on Non-Small Cell Lung Cancer Trial of Ivonescimab

Y

Janux Therapeutics, Inc. (JANX) Commences Patient Dosing of JANX011 in Autoimmune Trial

Y

Analysts See $100 Oil on Strait of Hormuz Disruption

Y

EU can sharply cut local battery prices with Made in Europe plan, T&E report says

Y

BlackRock Ramps Up Risk in Its Target-Date Funds

Y

Dozens of Issuers Win Dual Share Class Approval. Rolling Them Out Won’t Be as Easy

Y

Wedbush Expands IVES Franchise With New Autocallable ETF

Y

Trump’s Retirement Savings Plan Offers Potential Bonanza for Firms Like Fidelity

Y

OpenAI Wins Pentagon Work as Altman Tries to Square Circular Deals after Raising $110B

Y

POWER DIGEST [March 2026]

Y

Engine Power Plants Surge as Data Centers Drive Unprecedented Demand

Y

Dow Jones Futures Fall, Oil Prices Jump Amid U.S.-Iran Attacks

Y

Oil Prices Soar Amid Escalating Middle East Conflict

Y

Oil climbs in early trading, diesel rising more than crude

Y

Risk-off assets surge as markets react to conflict in Iran

Y

AI disruption looms over markets with US jobs data on tap

Y

How China’s Rare Earth Ban Backfired into a U.S. Tech Breakthrough

Y